Does IMIPENEM Cause Product use in unapproved indication? 85 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 85 reports of Product use in unapproved indication have been filed in association with IMIPENEM. This represents 4.5% of all adverse event reports for IMIPENEM.
85
Reports of Product use in unapproved indication with IMIPENEM
4.5%
of all IMIPENEM reports
12
Deaths
22
Hospitalizations
How Dangerous Is Product use in unapproved indication From IMIPENEM?
Of the 85 reports, 12 (14.1%) resulted in death, 22 (25.9%) required hospitalization, and 6 (7.1%) were considered life-threatening.
Is Product use in unapproved indication Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for IMIPENEM. However, 85 reports have been filed with the FAERS database.
What Other Side Effects Does IMIPENEM Cause?
Drug ineffective (351)
Off label use (202)
Condition aggravated (138)
Vomiting (137)
Drug resistance (117)
Nausea (111)
Dyspnoea (97)
Diarrhoea (90)
Pyrexia (90)
Thrombocytopenia (84)
What Other Drugs Cause Product use in unapproved indication?
DUPILUMAB (33,452)
DICLOFENAC (12,197)
METHOTREXATE (8,930)
PREDNISONE (7,625)
RITUXIMAB (7,519)
MYCOPHENOLATE MOFETIL (5,910)
ACETAMINOPHEN (5,819)
CYCLOPHOSPHAMIDE (5,750)
RISPERIDONE (5,551)
TACROLIMUS (5,057)
Which IMIPENEM Alternatives Have Lower Product use in unapproved indication Risk?
IMIPENEM vs IMIPRAMINE
IMIPENEM vs IMIQUIMOD
IMIPENEM vs IMITREX
IMIPENEM vs IMMUNE GLOBULIN NOS
IMIPENEM vs IMPLANON